What Are the 3 Best Bargain Artificial Intelligence (AI) Stocks to Buy Right Now?
Nvidia, ASML, and Amazon provide diverse opportunities for gaining AI exposure.
Although they seem richly valued, all three are all trading at discounts to their historical valuations.
10 stocks we like better than Nvidia ›
In April when the S&P 500 sunk about 19%, bargain hunters were having a field day. Today, however, the opportunities to find quality artificial intelligence (AI) stocks hanging on the discount rack may seem fewer and farther between.
But that's not to say that they don't exist.
In fact, today seems like a great time to pick up shares of Nvidia (NASDAQ: NVDA), ASML (NASDAQ: ASML), and Amazon (NASDAQ: AMZN) while they're sitting in the bargain bin.
Trading today at around 52.5 times operating cash flow, Nvidia stock certainly doesn't seem like it's a value opportunity at first glance. Before making this determination, however, you'd be wise to remember that it's often useful to consider a stock's valuation in context of its historical valuation. In doing so, you'd find Nvidia stock's five-year average cash-flow multiple is 55.1, illustrating its less expensive valuation today.
Similarly, shares of Nvidia seem admittedly higher trading at 53 times trailing earnings, but since they have a five-year average P/E ratio of 70.2, shares seem attractively priced right now.
A semiconductor stalwart, investors would be hard pressed to find a company that supports advancement of the AI industry as much as Nvidia thanks to the graphics processing units it designs for data centers, where AI computing occurs. Additionally, Nvidia has ownership stakes in a variety of AI companies that are driving innovation in a variety of fields including generative AI and healthcare.
Unsurprisingly, the production of sophisticated semiconductors that companies rely on to drive AI innovation is far from a simple process. That's where ASML comes in. The company provides hardware, software, and services that help facilitate the mass production of microchips found in AI applications. Most notably, the company provides semiconductor makers with extreme ultraviolet (EUV) lithography systems -- systems that enable the printing of the smallest features on microchips at the highest density. This is an invaluable tool for advanced semiconductor makers such as ASML customers Taiwan Semiconductor Manufacturing and Intel.
It's hard to overstate the allure of ASML with respect to the vital role it plays in helping chipmakers; it's currently the only company worldwide to manufacture EUV lithography systems.
Like with Nvidia, ASML stock's trailing P/E ratio of 33.7 might not shout "bargain," but considering its five-year trailing earnings multiple of 40.8, the current valuation seems more compelling.
Climbing 2.6% since the start of 2025, Amazon stock has failed to keep pace with the S&P 500, which has risen 6.4% as of this writing. With the lack of uncertainty regarding tariffs and how they will impact the company's retail business, investors have chosen to keep their distance -- unlike 2024 when Amazon stock soared more than 44%.
While the stock's lackluster rise in 2025 may be disheartening for current shareholders, it helps to provide a good entry point for prospective investors. Currently, shares are priced 36.7 times trailing earnings -- a hefty discount to their five-year average P/E of 64.1.
From its cloud platform, Amazon Web Services, which supports its customers develop their own AI resources, to the development of AI tools like the virtual assistant Alexa and Amazon Q, an AI assistant used in workplace settings, the company has broad exposure to the AI industry. Plus, there's the numerous ways that Amazon is leveraging AI in everything it owns, making it even clearer that this AI powerhouse has a great opportunity to flourish in the years ahead.
While it's always important to focus on the present and look toward the future, taking a peak at the past can also prove to be pretty helpful -- especially with respect to valuing stocks. At first glance, Nvidia, ASML, and Amazon may all seem to sport rich price tags, but, when taking into account their historical valuations, it becomes much clearer how they are all available at a discount right now.
All three companies provide varying opportunities, but Nvidia is arguably the best choice right now for those seeking the most concentrated exposure to the burgeoning field of AI.
Before you buy stock in Nvidia, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Nvidia wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $671,477!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,010,880!*
Now, it's worth noting Stock Advisor's total average return is 1,047% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join .
See the 10 stocks »
*Stock Advisor returns as of July 14, 2025
John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Scott Levine has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends ASML, Amazon, Intel, Nvidia, and Taiwan Semiconductor Manufacturing. The Motley Fool recommends the following options: short August 2025 $24 calls on Intel. The Motley Fool has a disclosure policy.
What Are the 3 Best Bargain Artificial Intelligence (AI) Stocks to Buy Right Now? was originally published by The Motley Fool

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Insider
24 minutes ago
- Business Insider
Closing Bell Movers: Victory Capital gains on S&P 400 inclusion
In the opening 90 minutes of the evening session, U.S. equity futures are down slightly with a 0.2% decline in S&P 500, Nasdaq 100, and Dow Industrials. In Energy, WTI Crude remains below $67 per barrel following a very large build crude stocks reported by API, while Metals are little changed after second consecutive session of losses in Gold and Silver. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Financials, Materials, and Health Care led the S&P 500 to the downside, while Tech – particularly large/mega-cap – remained resilient. Nvidia (NVDA) made new all-time highs with a 4% gaining session and 5 out of 7 Mag-7 names ended the day higher despite the selloff in the broader index. Reporting financials, especially Blackrock (BLK) and Wells Fargo (WFC) were softer after their Q2 numbers. Sentiment was also weighed down by the uptick in June CPI data, with expectations of the start of Fed easing by September no longer looking like a slam dunk, according to Fed Funds futures markets. Check out this evening's top movers from around Wall Street, compiled by The Fly. HIGHER –
Yahoo
27 minutes ago
- Yahoo
Jim Cramer Calls Insmed 'Very Speculative'
Insmed Incorporated (NASDAQ:INSM) is one of the stocks on Jim Cramer's radar. A caller noted that Cramer has not been quick to recommend biotech companies in the past and inquired about Insmed. In response, he remarked: 'Okay, one of the reasons I don't recommend a lot of them is because they lose so much money, and it's okay as a spec, but I don't put any specs in the Charitable Trust. None. That one's very speculative. It has lost a huge amount of money, so it's very hard for me to get a handle on it.' A biopharmaceutical research team taking notes in front of a laboratory's microscope. Insmed (NASDAQ:INSM) develops and markets therapies for serious and rare diseases, with approved treatment for nontuberculous mycobacterial lung infections and a pipeline targeting conditions like bronchiectasis, pulmonary hypertension, and Duchenne muscular dystrophy. TimesSquare Capital Management stated the following regarding Insmed Incorporated (NASDAQ:INSM) in its Q1 2025 investor letter: 'New to the strategy was Insmed Incorporated (NASDAQ:INSM), a biopharma developer of treatments for various pulmonary diseases. Insmed has one commercially approved treatment for lung infections, however, we see its developing product Brensocatib as driving future price appreciation. In 2024, Insmed reported positive data for Brensocatib in bronchiectasis, paving the way for a 2025 FDA approval and commercial launch. This February, the FDA announced it was giving Brensocatib's priority review with an expected action date in August.' While we acknowledge the potential of INSM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
27 minutes ago
- Yahoo
Jim Cramer on Ouster: 'I'm Going to Say No to Speculative'
Ouster, Inc. (NASDAQ:OUST) is one of the stocks on Jim Cramer's radar. During the lightning round, a caller asked what Cramer thinks of the company, and he commented: 'Yeah, you know it's a LiDAR company… and the LiDAR companies have been losing a fortune. I don't think that there's anything investible in, honestly, in autonomous, other than Tesla. Waymo's not enough, of Alphabet. So I'm going to say no to speculative.' A group of robotic vehicles navigating a terrain autonomously utilizing the company's 3D vision technology. Ouster (NASDAQ:OUST) designs and supplies high-resolution lidar sensors and software solutions used in automotive, industrial, robotics, and smart infrastructure applications. The company's products include scanning and solid-state sensors, along with platforms for perception, traffic management, and safety. In May 2024, Cramer showed bearish sentiment toward the stock as he said: 'Oh man, that's a lidar play. I'll tell you — I've not been recommending any of those EV plays that are losing money. They do a lot of autonomous vehicles, but I can't go there because I'm not recommending stocks where they just have not been able to even get near a profit.' While we acknowledge the potential of OUST as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data